30-Second Takeaway
- Sustained midlife physical activity and small daily reductions in sedentary time meaningfully lower all-cause mortality.
- Planetary Health Diet adherence and hypertension control remain underused, high-yield levers for cardiometabolic risk reduction.
- Cancer screening in practice shows substantial overuse and underuse; digital and multilevel interventions can improve appropriateness and equity.
Week ending March 28, 2026
Physical activity, cardiometabolic risk, and screening behaviors: actionable levers for prevention
Sustained midlife MVPA halves all-cause mortality in Australian women
In 11,169 Australian women followed from their early 50s to early 70s, sustained adherence to WHO MVPA recommendations reduced mortality. Consistently achieving ≥150 minutes/week of MVPA over 15 years was associated with about 50% lower all-cause mortality versus consistent nonadherence. Evidence for reductions in CVD and cancer mortality was suggestive but imprecise, with wide confidence intervals. Starting to meet MVPA recommendations only in the mid-50s showed less clear mortality benefit.
Replacing sitting with any-intensity activity lowers mortality in older adults
This two-cohort study of over 330,000 older adults in China and the UK examined substituting sedentary time with physical activity. Each additional 30 minutes/day of sedentary behavior was associated with higher all-cause mortality in both cohorts. Replacing 30 minutes/day of sedentary time with light, moderate, or vigorous activity reduced mortality risk in China, with similar benefits across intensities. In the UK cohort, substituting vigorous activity conferred the largest risk reduction per 30 minutes/day.
Higher Planetary Health Diet adherence modestly reduces mortality and CVD risk
This meta-analysis pooled 23 prospective cohorts evaluating adult adherence to the Planetary Health Diet. Highest versus lowest adherence was associated with roughly 17% lower all-cause mortality and 18% lower total cardiovascular disease risk. Cardiovascular mortality was reduced by about 16%, with lower risks of coronary and ischemic heart disease, heart failure, and atrial fibrillation. Dose-response analyses showed risk reductions beginning around the third adherence quintile and strengthening at higher adherence levels.
Global hypertension burden reaches 1.71 billion adults with widening LMIC gaps
This systematic review synthesized 287 population-based surveys from 119 countries between 2000 and 2020. In 2020, about one-third of adults worldwide had hypertension, totaling 1.71 billion people, most living in low- and middle-income countries. From 2000 to 2020, age-standardized prevalence slightly decreased in high-income countries but increased in low- and middle-income countries. Awareness, treatment, and control improved substantially in high-income settings but remained low in low- and middle-income countries, where control reached only 13.6%.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.